You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Chronic Kidney Disease Co-Management: Removing Barriers, Reducing Inequities, and Improving Outcomes

  • Authors: Kirk Campbell, MD; David Halpern, MD, MPH, FACP
  • CME / CE Released: 11/17/2023
  • Valid for credit through: 11/17/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™

    Nurses - 1.00 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Pharmacists - 1.00 Knowledge-based ACPE (0.100 CEUs)

    Physician Assistant - 1.00 AAPA hour(s) of Category I credit

    ABIM Diplomates - Maximum of 1.00 ABIM MOC points

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

Physicians, Pharmacists, Physician Assistants, Nurse Practitioners, Nurses

The overarching purpose of this program is to learn from primary care and nephrology presenters about the importance of increasing collaboration among generalists, specialists, and patients to improve chronic kidney disease (CKD) outcomes and health equity using population health principles. This program provides key considerations, resources, and conversation starters for learners to take back to their institution. This information can inform their practice when determining clear guidance, policies, and workflows for appropriately managing referrals and delineating roles and expectations across all disciplines involved along the continuum of CKD care.

Upon completion of this activity, participants will be able to:

  1. Identify opportunities to optimize management of advancing CKD
  2. Articulate barriers that contribute to inequities in kidney care and hinder effective co-management of CKD
  3. Describe overarching care modifications that can improve CKD population health


Declaration of Disclosure

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

All of the relevant financial relationships listed for faculty and planners have been mitigated according to NKF policies. Please see the faculty tab within each course for all disclosure information.

Unlabeled/Investigational Use

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.


  • Kirk Campbell, MD

    Professor of Medicine - Division of Nephrology
    Icahn School of Medicine at Mount Sinai
    New York, New York


    Kirk Campbell, MD, has the following relevant financial relationships:
    Consultant or advisor for: Calliditas; Chinook; Goldfinch; Travere

  • David Halpern, MD, MPH, FACP

    Senior Medical Director – Quality and Population Health
    Duke Primary Care
    Durham, North Carolina


    David Halpern, MD, MPH, FACP, has no relevant financial relationships.

Planning Committee Disclosures

  • Andrew Bzowyckyj, PharmD, BCPS, CDCES

    Scientific Director
    National Kidney Foundation
    New York, New York


    Disclosure: Served as an advisor for: Sanofi

  • Victoria Page, BSN, MBA

    National Kidney Foundation
    New York, New York


    Disclosure: Has no financial relationships with commercial interest(s).

  • Kathryn Troy, MPH

    Senior Director, Continuing Education
    National Kidney Foundation
    New York, New York


    Disclosure: Has no financial relationships with commercial interest(s).

Reviewer Disclosures

  • Beje Thomas, MD

    Associate Professor
    MedStar Georgetown University Hospital
    Washington, District of Columbia


    Disclosure: Has no financial relationships with commercial interest(s).

  • Adam Berliner, MD

    Nephrology Center of Maryland
    Baltimore, Maryland


    Disclosure: Has no financial relationships with commercial interest(s).

Accreditation Statements

Provided by National Kidney Foundation.


In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the American Academy of Physician Assistants (AAPA), to provide continuing education for the healthcare team.

    For Physicians

  • The National Kidney Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Nurses and Nurse Practitioners: Awarded 1.0 contact hours of continuing nursing education.

    Contact This Provider

    For Pharmacists

  • This knowledge-based enduring activity has been assigned Universal Activity Number JA0004461-0000-23-040-H01-P, for 1.0 contact hours (0.01 CEUs). To receive credit, learners must read the activity overview, learning objectives and faculty disclosures, complete the pre-test, review the content, complete the post-test with a minimum score of 75% (post-test may be taken up to 3 times) and electronic activity evaluation. An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact [email protected] if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit:

    Contact This Provider

  • For Physician Assistants

    National Kidney Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of  75%  on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Chronic Kidney Disease Co-Management: Removing Barriers, Reducing Inequities, and Improving Outcomes

Authors: Kirk Campbell, MD; David Halpern, MD, MPH, FACPFaculty and Disclosures

CME / CE Released: 11/17/2023

Valid for credit through: 11/17/2024, 11:59 PM EST


Learning Feedback Questions

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print